Hey Pears! I've always enjoyed your thoughts. CTSO is getting close to liftoff. Free hemoglobin numbers in the Cardiac Surgery Pilot Study will be released soon. Chan is holding them back due to protocol. He wants docs to see them first. I don't know the schedule for cardiac surgeon conferences, but expect one might be on tap in next month or two. Do you know when? Plus, Q4 is about to end, and Terumo took its first order and Fresenius is pumping CytoSorb. Loved the German insurance reimbursement approval, too. It all means more mo', mo' money. One issue might be currency adjustment due to Euro/Dollar, but overall, sales will likely increase nicely again, providing further proof of constantly strengthening growth trend. Excellent buy sub $5, if you can get it.